| Members |
targetComponentId |
| Time symptom lasts NOS |
Time symptom lasts |
| Time zone syndrome |
Jet lag (finding) |
| Timed unsupported steady stand test |
Timed unsupported steady stand time |
| Timolol maleate 0.25% ophthalmic solution |
Timolol (as timolol maleate) 2.5 mg/mL eye drops |
| Timolol maleate 0.5% |
Product containing precisely timolol (as timolol maleate) 5 milligram/1 milliliter conventional release eye drops (clinical drug) |
| Timolol maleate 0.5% ophthalmic solution |
Product containing precisely timolol (as timolol maleate) 5 milligram/1 milliliter conventional release eye drops (clinical drug) |
| Timolol maleate+bendroflumethiazide |
Product containing bendroflumethiazide and timolol (medicinal product) |
| Tiotropium 18microgram inhalation powder capsule |
Tiotropium (as tiotropium bromide) 18 microgram/actuation powder for inhalation |
| Tiotropium 18microgram inhalation powder capsule with device |
Tiotropium (as tiotropium bromide) 18 microgram/actuation powder for inhalation |
| Tis (0): Carcinoma in situ (limited to fallopian tube mucosa) |
cTis |
| Tis (0): Carcinoma in situ (vagina) |
cTis |
| Tis category |
cTis |
| Tis: Carcinoma in situ ("flat tumor" of urinary bladder) |
cTis |
| Tis: Carcinoma in situ (endometrium/uterine cervix) |
cTis |
| Tis: Carcinoma in situ |
cTis |
| Tis: Epithelium only (carcinoma in situ, no invasion) |
cTis |
| Tis: Intratubular germ cell neoplasia (carcinoma in situ, testis) |
cTis |
| Tis: Tumor invades lamina propria (gastrointestinal tumor) |
American Joint Committee on Cancer cTis(LAMN) (qualifier value) |
| Tis: Tumor invades muscularis mucosae (colon/rectum) |
cTis |
| Tissue culture for chromosome analysis, more complex procedure with special extra counts |
Chromosome analysis |
| Tissue injection for local action |
Injection |
| Tissue injection for local action NOS |
Injection |
| Tissue injection for local action NOS |
Injection |
| Tissue kallikrein |
Kininogen |
| Tissue processing technique, complex, embed, cut and stain, per autopsy |
Tissue processing technique |
| Tissue processing technique, complex, embed, cut and stain, per surgical specimen |
Tissue processing technique |
| Titanium dioxide 20% paste |
Product containing only titanium dioxide (medicinal product) |
| Tobacco dependence with current use |
Tobacco dependence syndrome |
| Tobramycin 0.3%/fluorometholone 0.1% ophthalmic suspension |
Product containing precisely fluorometholone acetate 1 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) |
| Tobramycin 1.2g powder for injection solution vial |
Tobramycin (as tobramycin sulfate) 1.2 g powder for solution for injection vial |
| Tobramycin 1.2mg/mL injection |
Tobramycin (as tobramycin sulfate) 1.2 g powder for solution for injection vial |
| Tobramycin 300mg/5mL nebulizer solution |
Product containing precisely tobramycin 60 milligram/1 milliliter conventional release solution for nebulizer (clinical drug) |
| Tobramycin 60mg/mL solution |
Product containing precisely tobramycin 60 milligram/1 milliliter conventional release solution for nebulizer (clinical drug) |
| Tocilizumab 20mg/mL conventional release solution for injection |
Tocilizumab only product in parenteral dose form |
| Tocilizumab 20mg/mL solution for intravenous infusion |
Tocilizumab only product in parenteral dose form |
| Tocopherol |
Vitamin E and/or vitamin E derivative (substance) |
| Toe flap |
Flap (substance) |
| Tolnaftate+chlorhexidine hydrochloride |
Product containing chlorhexidine and tolnaftate (medicinal product) |
| Tolterodine 4mg m/r capsule |
Product containing only tolterodine in oral dose form (medicinal product form) |
| Tolterodine L-tartrate 4mg m/r capsule |
Product containing only tolterodine in oral dose form (medicinal product form) |
| Tolterodine L-tartrate 4mg m/r capsule |
Product containing only tolterodine in oral dose form (medicinal product form) |
| Tolterodine L-tartrate 4mg prolonged-release oral capsule |
Product containing only tolterodine in oral dose form (medicinal product form) |
| Tolterodine tartrate 2mg m/r capsule |
Product containing only tolterodine in oral dose form (medicinal product form) |
| Tolterodine tartrate 2mg prolonged-release oral capsule |
Product containing only tolterodine in oral dose form (medicinal product form) |
| Tolterodine tartrate 4mg m/r capsule |
Product containing only tolterodine in oral dose form (medicinal product form) |
| Toluene diisocyanate specific extract |
Toluene-2-4-diisocyanate |
| Tomato - dietary |
Tomato (substance) |
| Tomilol |
Timolol (substance) |
| Tomography - NOS |
Tomographic imaging procedure (procedure) |
| Tomography - NOS |
Tomographic imaging procedure (procedure) |
| Tongue flap |
Flap (substance) |
| Tonic-clonic epilepsy |
Epilepsy |
| Tonsil (& peritonsillar region) |
Palatine tonsillar structure |
| Tooth attrition |
Excessive attrition of teeth |
| Tooth decalcification |
Incipient enamel caries |
| Tooth eruption disturbances NOS |
Tooth eruption disorder (disorder) |
| Tooth restoration NOS |
Restoration of tooth (procedure) |
| Tooth restoration NOS |
Restoration of tooth (procedure) |
| Topical compound dexamethasone preparation allergy |
Allergy to dexamethasone |
| Topical compound hydrocortisone preparation allergy |
Allergy to hydrocortisone (finding) |
| Topical corticosteroid, group I |
Glucocorticoid (substance) |
| Topical corticosteroid, group II |
Glucocorticoid (substance) |
| Topical corticosteroid, group III |
Glucocorticoid (substance) |
| Topical corticosteroid, group IV |
Glucocorticoid (substance) |
| Topical corticosteroid, group V |
Glucocorticoid (substance) |
| Topical corticosteroid, group VI |
Glucocorticoid (substance) |
| Topical dermatological preparation adverse reaction |
Adverse reaction to drug |
| Topical dexamethasone allergy |
Allergy to dexamethasone |
| Topical estradiol allergy |
Allergy to estradiol (finding) |
| Topical hydrocortisone allergy |
Allergy to hydrocortisone (finding) |
| Topical prednisolone allergy |
Allergy to prednisolone |
| Topical salicylic acid allergy |
Allergy to salicylic acid (finding) |
| Topical selenium |
Selenium |
| Topical sulfur |
Sulfur |
| Topotecan 1mg powder for infusion solution vial |
Topotecan (as topotecan hydrochloride) 1 mg powder for solution for injection vial |
| Torday's elephant shrew |
Family Macroscelididae |
| Torek operation for orchiopexy |
Orchidopexy |
| Torsemide 10mg/mL injection solution ampule |
Product containing only torasemide in parenteral dose form (medicinal product form) |
| Torulopsis |
Candida |
| Torulopsis candida |
Candida saitoana |
| Torulopsis glabrata |
Candida glabrata (organism) |
| Torulopsis pintolopesii |
Candida pintolopesii |
| Total biopterins |
Substance with biopterin structure (substance) |
| Total colectomy, ileostomy and creation of rectal fistula however further qualified |
Total colectomy, ileostomy and rectal mucous fistula |
| Total estimated daily energy intake |
Estimated quantity of intake of energy in 24 hours (observable entity) |
| Total excision of organ NOC |
Complete excision of organ (procedure) |
| Total prosthetic replacement of hip joint not using cement NOS |
Uncemented prosthetic total arthroplasty of hip joint |
| Total prosthetic replacement of hip joint using cement NOS |
Cemented prosthetic total arthroplasty of hip joint (procedure) |
| Tourette's disorder |
Gilles de la Tourette's syndrome |
| Toxemia of pregnancy |
Pre-eclampsia (disorder) |
| Toxic effect |
Poisoning |
| Toxic effect from eating shellfish |
Toxic effect from eating shellfish (disorder) |
| Toxic effect from noxious substance eaten as food, NEC |
Food poisoning |
| Toxic effect of chiefly nonmedicinal substance, NEC |
Toxic effect of chiefly nonmedicinal substance |
| Toxic effect of hydrocarbon gas, NEC |
Toxic effect of hydrocarbon gas |
| Toxic effect of nitroderivatives and aminoderivatives of benzene and its homologues |
Poisoning caused by substance with benzene structure (disorder) |
| Toxic effect of non-petroleum-based solvent |
Toxic effect of nonpetroleum-based solvent |
| Toxic effect of noxious substance eaten as food |
Food poisoning |
| Toxic effect of other nonpetroleum-based solvent, NEC |
Toxic effect of nonpetroleum-based solvent |
| Toxic effect of tobacco and nicotine |
Nicotine poisoning |
| Toxic encephalopathy |
Toxic encephalopathy |
FHIR